Using modern, genome-wide screening and data analysis, researchers at the University of Nottingham pinpointed a feature of babies’ DNA that can increase mothers’ risk of developing pre-eclampsia. The study found DNA variations close to the gene that makes a protein called sFlt-1 that increase the risk of the condition. At high levels, sFlt-1 released from the placenta into the mother’s bloodstream can injure blood vessels, leading to high blood pressure, kidney, liver or brain damage (all features of pre-eclampsia). Researchers hope that the study will lead to more effective prevention and treatment of pre-eclampsia.
The following reviews from our clients do not constitute a guarantee, warranty, or prediction regarding the outcome of another legal matter. The cases mentioned in the reviews are illustrative of some of the matters previously handled by Grant & Eisenhofer involving various areas of birth injury law. These reviews are endorsements.
The following reviews from our clients do not constitute a guarantee, warranty, or prediction regarding the outcome of another legal matter. The cases mentioned in the reviews are illustrative of some of the matters previously handled by Grant & Eisenhofer involving various areas of birth injury law. These reviews are endorsements.